New drug aims to shield autoimmune patients from Life-Threatening infections
Disease control
Not yet recruiting
This study tests whether Panzyga, an antibody treatment, can prevent major infections in 360 adults with autoimmune or rheumatic conditions who have low antibody levels and are receiving B-cell depletion therapy. Participants will receive either Panzyga or a placebo, and research…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 14, 2026 12:05 UTC